Herb Cross Atreca, Inc. (BCEL) insider trading activity

BCEL Quotes by TradingView

Herb Cross is Chief Financial Officer of Atreca, Inc.. Currently has a direct ownership of 72,817 shares of BCEL, which is worth approximately $0. The most recent transaction as insider was on Aug 02, 2023, when has been sold 5,487 shares (Class A Common Stock) at a price of $0.95 per share, resulting in proceeds of $5,212. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 72.8K
0% 3M change
0% 12M change
Total Value Held $0

HERB CROSS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 02 2023
SELL
Open market or private sale
$5,212 $0.95 p/Share
5,487 Reduced 7.01%
72,817 Class A Common Stock
Feb 09 2023
BUY
Grant, award, or other acquisition
-
43,750 Added 35.84%
78,304 Class A Common Stock
Sep 02 2022
SELL
Open market or private sale
$13,610 $1.78 p/Share
7,646 Reduced 18.12%
34,554 Class A Common Stock
Sep 09 2021
BUY
Grant, award, or other acquisition
-
42,200 Added 50.0%
42,200 Class A Common Stock

Also insider at

HGEN
HUMANIGEN, INC Healthcare
Chief Financial Officer
BCAC
Brookline Capital Acquisition Corp. Financial Services
Director
JSPR
Jasper Therapeutics, Inc. Healthcare
Chief Financial Officer
HC

Herb Cross

Chief Financial Officer
South San Francisco, CA

Track Institutional and Insider Activities on BCEL

Follow Atreca, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCEL shares.

Notify only if

Insider Trading

Get notified when an Atreca, Inc. insider buys or sells BCEL shares.

Notify only if

News

Receive news related to Atreca, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BCEL